Page 176 - 79_01

J.
R.
Lacadena
y
F.
Mayor
Menéndez

pluripotent
stem
cells
generated
from
patients
with
ALS
can
be
differentiated
into
motor

neurons.
Science
321,
1218-­-1221
(2008).

39. Park,
I.H.
et
al.
Disease-­-specific
induced
pluripotent
stem
cells.
Cell
134,
877-­-886
(2008).

40. Ebert,
A.D.;
Yu,
J.;
Rose
Jr,
F.F.;
Mattis,
V.B.;
Lorson,
C.L.;
Thomson,
J.A.;
Svendsen,
C.N.

Induced
pluripotent
stem
cells
from
a
spinal
muscular
atrophy
patient.
Nature
457,
277-­-
281
(2009).

41. Marchetto,
M.C.N.;
Carromeu,
C.;
Acab,
A.;
Yu,
D.;
Yeo,
G.W.
;
Mu,
Y.L.
et
al.
A
model
for

neural
development
and
treatment
of
Rett
syndrome
using
human
induced
pluripotent

stem
cells.
Cell
143,
527-­-539
(2010).

42. Rashid,
S.T.;
Corbineau,
S.;
Hannan,
N.
;
Marciniak,
S.J.
;
Miranda,
E.
;
Alexander,
G.
et
al.

Modeling
inherited
metabolic
disorders
of
the
liver
using
human
induced
pluripotent

stem
cells.
J.
Clin.
Invest.
120,
3127-­-3136
(2010).

43. Liu,
G-­-H.;
Barkho,
B.Z.;
Ruiz,
S.;
Diep,
D.;
Qu,
J.;
Yang,
S-­-L.;
panopoulos,
A.D.;
Suzuki,
K.;

Kurian,
L.;
Walsh,
C.;
Thompson,
J.;
Boue,
S.;
Fung,
H.L.;
Sancho-­-Martínez,
I.;
Zhang,
K.;

Yates,
J.
III;
Izpisua
Belmonte,
J.C.
Recapitulation
of
premature
ageing
with
iPSCs
from

Hutchinson-­-Gilford
progeria
syndrome.
Nature
doi:10.1038/nature09879
(2011)

44. Koch,
P.;
Breuer,
P.;
Peitz,
M.;
Jungverdorben,
J.
;
Kesavan,
J.;
Poppe,
D.
et
al.
Excitation-­-
induced
ataxin-­-3
aggregation
in
neurons
from
patients
with
Machado-­-Joseph
disease.

Nature
480,
543-­-546
(2011).

45. IsraeL,
M.A.;
Yuan,
S.H.;
Bardy,
C.;
Reyna,
S.M.;
Mu,
Y.;
Herrera,
C.
et
al.
(2012)
Probing

sporadic
and
familial
Alzheimer’s
disease
using
induced
pluripotent
stem
cells.
Nature

482,
216-­-220
(2012).

46. The
HD
iPSC
Consortium.
Induced
pluripotente
stem
cells
from
patients
with
Huntington’s

disease
show
CAG-­-repeat-­-expansion-­-associated
phenotypes.
Cell
Stem
Cell
11,
264-­-278

(2012).

47. Liu,
G-­-H;
Qu,
J.;
Suzuki,
K.;
Nivet,
E.;
Li,
M.;
Montserrat,
N.;
Yi,
F.
;
Ruiz,
X.S.
;
Zhang,
W.
;

Wagner,
U.;
Kim,
A.;
Ren,
B.;
Li,
Y.;
Goebl,
A.;
Rupa,
J.K.;
Soligalla,
D.;
Dubova,
I.;
Thomson,

J.;
Yates
III,
J.;
rodriguez,
G.;
Sancho-­-Martínez,
E.I.;
Izpisua
Belmonte,
J.C.
Progressive

degeneration
of
human
neural
stem
cells
caused
by
pathogenic
LRRK2.
Nature

doi:10.1038/nature
11557
(2012).

48. Brennand,
K.J.;
Simone,
A.;
Jou,
J.;
Gelboin-­-Burkhart,
C.;
Tran,
N.;
Sanger,
S.
et
al.
Modelling

squizophrenia
using
human
induced
pluripotent
stem
cells.
Nature
473,
221-­-225
(2011).

49. Kennedy,
D.
Editorial.
Breakthrough
of
the
year.
Science
318:1833
(2007).
Ford,
M.

Science
magazine’s
top
10
breakthroughs
of
the
year.
Science
(2008).

50. Evans,
M.J.;
Kaufman,
M.H.
Establishment
in
culture
of
pluripotential
cells
from
mouse

embryos.
Nature
292,
154-­-156
(1981).

51. Thomson,
J.A.;
Itskovitz-­-Eldor,
J.;
Shapiro,
S.S.;
Waknitz,
M.A.;
Swiergiel,
J.J.;
Marshall,
V.S.;

Jones,
J.M.
Embryonic
stem
cells
derived
from
human
blastocystes.
Science
282,
1145-­-
1147
(1998).

52. Cibelli,
J.B.;
Kiessling,
A.A.;
Cunniff,
K.;
Richards,
C.;
Lanza,
R.P.;
West,
M.D.
Somatic
cell

nuclear
transfer
in
humans:
Pronuclear
and
early
embryonic
development.
E-­-biomed:
The

Journal
of
Regenerative
Medicine
2,
25-­-31
(2001).
Cibelli,
J.B.;
Lanza,
R.P.;
West,
M.D.;

Ezzell,
C.
The
first
human
cloned
embryo.
Scient.
Am.
286,
42-­-49
(2002).

53. NIH.
http://www.ClinicalTrials.gov

(diciembre
2012)

54. Hadorn,
E.
Problems
of
determination
and
transdetermination.
Brookhaven
Symp.
Biol.

No.
18
(Genetic
control
of
differentiation),
148-­-161
(1965).

55. Frisén,
J.;
Lendahl,
U.;
Perimann,
T.
Mature
cells
can
be
reprogrammed
to
become

pluripotent.
The
2012
Nobel
Prize
in
Physiology
or
Medicine
–
Advanced
Information.

http://Nobelprize.org
(2012)

170